Disclaimer I do not have medical training.
Articles on Camostat and Bromhexine hydrocloride in regards to Covid 19
Repurposing host-based therapeutics to control coronavirus and influenza virus
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
The Impact of Camostat Mesilate on COVID-19 Infection (CamoCO-19)
COVID-19 Registered Trials – and analysis
A reappraisal of the mucoactive activityand clinical efficacy of bromhexine